News Lilly joins CGRP race to cure migraine Eli Lilly are gearing up to announce details from the latest Emgality analysis, which can potentially push the biotech to the leading pack of the migraine cure race, among Allergan, Amgen a
News AstraZeneca and Lilly’s Alzheimer’s drug fails trial The battle to develop a drug to treat Alzheimer’s disease has been dealt a blow following disappointing phase 3 trial results.
News Lilly and Alder showcase latest migraine drug data Lilly and Alder take on the might of Novartis and Amgen
News Novartis/Amgen migraine jab works in tough-to-treat patients Novartis continues to build the case for its Aimovig migraine injection,with data showing it works in a tough-to-treat patient group.
News Bayer opens Berlin incubator and welcomes first resident Bayer's network of Co.Lab life sciences incubators has expanded once again with the official opening of a site in Berlin, its first in Europe
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.